The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
Open accessAbstract
In silico drug target identification, which includes many distinct algorithms for finding disease genes and proteins, is the first step in the drug discovery pipeline. When the 3D structures of the targets are available, the problem of target identification is usually converted to finding the best interaction mode between the potential target candidates and small molecule probes. Pharmacophore, which is the spatial arrangement of features essential for a molecule to interact with a specific target receptor, is an alternative method for achieving this goal apart from molecular docking method. PharmMapper server is a freely accessed web server designed to identify potential target candidates for the given small molecules (drugs, natural products or other newly discovered compounds with unidentified binding targets) using pharmacophore mapping approach. PharmMapper hosts a large, in-house repertoire of pharmacophore database (namely PharmTargetDB) annotated from all the targets information in TargetBank, BindingDB, DrugBank and potential drug target database, including over 7000 receptor-based pharmacophore models (covering over 1500 drug targets information). PharmMapper automatically finds the best mapping poses of the query molecule against all the pharmacophore models in PharmTargetDB and lists the top N best-fitted hits with appropriate target annotations, as well as respective molecule's aligned poses are presented. Benefited from the highly efficient and robust triangle hashing mapping method, PharmMapper bears high throughput ability and only costs 1 h averagely to screen the whole PharmTargetDB. The protocol was successful in finding the proper targets among the top 300 pharmacophore candidates in the retrospective benchmarking test of tamoxifen. PharmMapper is available at http://59.78.96.61/pharmmapper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
The Universal Protein Resource (UniProt)
Bairoch, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki070 · Cited by 3,774
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
Wolber, G., & Langer, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049885e · Cited by 1,954
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Wang, R., Fang, X., Lu, Y., & Wang, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030580l · Cited by 1,133
Virtual ligand screening: strategies, perspectives and limitations
Klebe, G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.012 · Cited by 664
PDBsum: a web-based database of summaries and analyses of all PDB structures
Laskowski, R. A., Hutchinson, E. G., Michie, A. D., Wallace, A. C., Jones, M. L., & Thornton, J. M. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01140-7 · Cited by 628
The Universal Protein Resource (UniProt)
The UniProt Consortium (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl929 · Cited by 569
TarFisDock: a web server for identifying drug targets with docking approach
Li, H., Gao, Z., Kang, L., Zhang, H., Yang, K., Yu, K., Luo, X., Zhu, W., Chen, K., Shen, J., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl114 · Cited by 420
Self-citationFrom atoms and bonds to three-dimensional atomic coordinates: automatic model builders
Sadowski, J., & Gasteiger, J. (1993) · Chemical Reviews · doi:10.1021/cr00023a012 · Cited by 414
PDTD: a web-accessible protein database for drug target identification
Gao, Z., Li, H., Zhang, H., Liu, X., Kang, L., Luo, X., Zhu, W., Chen, K., Wang, X., & Jiang, H. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-104 · Cited by 288
Self-citationChemogenomic approaches to rational drug design
Rognan, D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707307 · Cited by 269
Xie, L., Li, J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000387 · Cited by 247
Finding New Tricks For Old Drugs: An Efficient Route For Public-Sector Drug Discovery
O'Connor, K. A., & Roth, B. L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1900 · Cited by 215
Quantifying the Relationships among Drug Classes
Hert, J., Keiser, M. J., Irwin, J. J., Oprea, T. I., & Shoichet, B. K. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8000259 · Cited by 169
Fleming, C. D., Bencharit, S., Edwards, C. C., Hyatt, J. L., Tsurkan, L. G., Bai, F., Fraga, C. H., Morton, C. L., Howard-Williams, E. L., Potter, P. M., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.016 · Cited by 147
Nilsson, U. W., Garvin, S., & Dabrosin, C. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9335-4 · Cited by 104
Bender, A., Young, D. W., Jenkins, J. L., Serrano, M., Mikhailov, D., Clemons, P. A., & Davies, J. W. (2007) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620707782507313 · Cited by 95
Multiple Targeting by the Antitumor Drug Tamoxifen: A Structure-Activity Study
de Médina, P., Favre, G., & Poirot, M. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043352696 · Cited by 93
Computational analysis of ligand relationships within target families
Bajorath, J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.044 · Cited by 92
Steindl, T. M., Schuster, D., Wolber, G., et al. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9066-y · Cited by 65
Searching for pharmacophores in large coordinate data bases and its use in drug design.
Sheridan, R. P., Rusinko, A., Nilakantan, R., & Venkataraghavan, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8165 · Cited by 62
Inhibition of estrone sulfatase and 17β-hydroxysteroid dehydrogenase by antiestrogens
Santner, S. J., & Santen, R. J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90007-j · Cited by 60
Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal
Favoni, R. E., & de Cupis, A. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01252-8 · Cited by 51
Edmund Rodney, L. A. X., RUMSTADT, F., PLASCZYK, H., et al. (1983) · Endocrinology · doi:10.1210/endo-113-3-1043 · Cited by 40
Chemogenomics and biotechnology
Wüster, A., & Babu, M. M. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.01.004 · Cited by 39
Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen.
Nuwaysir, E. F., Daggett, D. A., Jordan, V. C., & Hc, P. (1996) · PubMed · Cited by 37
Rowlands, M., Budworth, J., Jarman, M., Hardcastle, I. R., McCague, R., & Gescher, A. J. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00186-4 · Cited by 36
Tamoxifen: the drug that came in from the cold
Hughes‐Davies, L., Caldas, C., & Wishart, G. C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605231 · Cited by 34
Chemogenomics: drug discovery's panacea?
Jacoby, E. (2006) · Molecular BioSystems · doi:10.1039/b603004c · Cited by 33
Cited by
Wang, X., Shen, Y., Wang, S., Li, S., Zhang, W., Liu, X., Lai, L., Pei, J., & Li, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx374 · Cited by 1,588
Self-citationLuo, T.-T., Lu, Y., Yan, S.-K., Xiao, X., Rong, X.-L., & Guo, J. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3064-0 · Cited by 638
Chen, Y.-C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.12.001 · Cited by 611
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
ZINCPharmer: pharmacophore search of the ZINC database
Koes, D. R., & Camacho, C. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks378 · Cited by 436
Metadata
- Authors
- Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, Z., Li, H., & Jiang, H.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-29
- Volume
- 38
- Issue
- suppl_2
- Pages
- W609-W614
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2104916446
- Cited by
- 967
- References
- 35
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.